Pharvaris N.V.
PHVSNASDAQHealthcare● Active
$31.59
+$0.50(+1.61%)
Market Cap$2.2B
P/E Ratio—
52W High$33.33
52W Low$15.91
Pharvaris N.V. (PHVS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PHVS · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
-$0.70
Est. -$0.82 · +14.8%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
PHVS reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 11, 2026 | -$0.74 | — | — | — | — | — |
| ▲ Q2 FY2026 | May 12, 2026 | -$0.82 | -$0.70 | +14.8% | — | — | — |
| ▼ Q2 FY2026 | Apr 2, 2026 | -$0.71 | -$0.85 | -18.3% | — | — | — |
| ▲ Q4 FY2025 | Nov 12, 2025 | -$0.78 | -$0.70 | +10.3% | — | — | — |
| ▼ Q3 FY2025 | Aug 12, 2025 | -$0.87 | -$0.94 | -8.1% | — | — | — |
| ▼ Q2 FY2025 | May 13, 2025 | -$0.80 | -$0.89 | -11.3% | — | — | — |
| — Q1 FY2025 | Mar 31, 2025 | — | -$0.93 | — | — | — | — |
| ▼ Q4 FY2024 | Nov 13, 2024 | -$0.66 | -$0.85 | -28.8% | — | — | — |
Q3 FY2026
Aug 11, 2026
EPS Actual
—
EPS Est.
-$0.74
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026Beat
EPS Actual
-$0.70
EPS Est.
-$0.82
EPS Surpr.
+14.8%
Revenue
—
Q2 FY2026
Apr 2, 2026Miss
EPS Actual
-$0.85
EPS Est.
-$0.71
EPS Surpr.
-18.3%
Revenue
—
Q4 FY2025
Nov 12, 2025Beat
EPS Actual
-$0.70
EPS Est.
-$0.78
EPS Surpr.
+10.3%
Revenue
—
Q3 FY2025
Aug 12, 2025Miss
EPS Actual
-$0.94
EPS Est.
-$0.87
EPS Surpr.
-8.1%
Revenue
—
Q2 FY2025
May 13, 2025Miss
EPS Actual
-$0.89
EPS Est.
-$0.80
EPS Surpr.
-11.3%
Revenue
—
Q1 FY2025
Mar 31, 2025
EPS Actual
-$0.93
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 13, 2024Miss
EPS Actual
-$0.85
EPS Est.
-$0.66
EPS Surpr.
-28.8%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.53 | $-0.53 | $-0.53 | 2 |
| Q3 FY2027 | $-0.67 | $-0.67 | $-0.67 | 2 |
| Q2 FY2027 | $-0.68 | $-0.68 | $-0.68 | 2 |
| Q1 FY2027 | $-0.69 | $-0.69 | $-0.69 | 3 |
| Q4 FY2026 | $-0.76 | $-0.76 | $-0.76 | 3 |
| Q3 FY2026 | $-0.72 | $-0.67 | $-0.64 | 7 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 12, 2026 | +14.8% | $29.95 | $31.25 | +4.34% |
| ▼ Q2 FY2026 | Apr 2, 2026 | -18.3% | $29.45 | $28.56 | -3.02% |
| ▲ Q4 FY2025 | Nov 12, 2025 | +10.3% | $24.12 | $25.81 | +7.01% |
| ▼ Q3 FY2025 | Aug 12, 2025 | -8.1% | $20.84 | $21.09 | +1.20% |
| ▼ Q2 FY2025 | May 13, 2025 | -11.3% | $16.81 | $16.11 | -4.16% |
| — Q1 FY2025 | Mar 31, 2025 | — | $15.80 | $15.70 | -0.63% |
| ▼ Q4 FY2024 | Nov 13, 2024 | -28.8% | $19.84 | $20.04 | +1.01% |
| ▼ Q3 FY2024 | Aug 14, 2024 | -3.5% | $18.28 | $16.90 | -7.55% |
Q2 FY2026+4.34%
Report Date
May 12, 2026
EPS Beat/Miss
+14.8%
Price Before
$29.95
Price After
$31.25
Q2 FY2026-3.02%
Report Date
Apr 2, 2026
EPS Beat/Miss
-18.3%
Price Before
$29.45
Price After
$28.56
Q4 FY2025+7.01%
Report Date
Nov 12, 2025
EPS Beat/Miss
+10.3%
Price Before
$24.12
Price After
$25.81
Q3 FY2025+1.20%
Report Date
Aug 12, 2025
EPS Beat/Miss
-8.1%
Price Before
$20.84
Price After
$21.09
Q2 FY2025-4.16%
Report Date
May 13, 2025
EPS Beat/Miss
-11.3%
Price Before
$16.81
Price After
$16.11
Q1 FY2025-0.63%
Report Date
Mar 31, 2025
EPS Beat/Miss
—
Price Before
$15.80
Price After
$15.70
Q4 FY2024+1.01%
Report Date
Nov 13, 2024
EPS Beat/Miss
-28.8%
Price Before
$19.84
Price After
$20.04
Q3 FY2024-7.55%
Report Date
Aug 14, 2024
EPS Beat/Miss
-3.5%
Price Before
$18.28
Price After
$16.90
Avg Beat Reaction+5.67%
Avg Miss Reaction-2.50%
Beat Rate2 / 8 quarters
Largest Move-7.55% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PHVS ends December
Pharvaris N.V. (PHVS) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $-0.70 — beating the analyst consensus of $-0.82 by +14.8%. The next PHVS earnings date is expected around September 1, 2026.
Each quarter, investors track PHVS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PHVS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PHVS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PHVS earnings · 5 questionsPharvaris N.V.'s next earnings report is expected around September 1, 2026. PHVS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PHVS historically reports after market close (AMC).
PHVS earnings datewhen is PHVS earningsPHVS next earnings datewhen does PHVS report earningsPHVS earnings calendar
▸ Source: FMP · Pharvaris N.V. SEC filings · US GAAP · Pharvaris N.V. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026